Exclusive

Publication

Byline

अधिवक्ता ने किया विरोध प्रदर्शन

बलिया, मई 20 -- बेल्थरारोड। तहसील के अधिवक्ताओं ने लखनऊ में हुई घटना को लेकर बुधवार को विरोध प्रदर्शन किया। कोर्ट परिसर के पास अवैध चैंबरों पर बुलडोजर कार्रवाई तथा अधिवक्ताओं पर कथित लाठीचार्ज के विरो... Read More


U.S. Crude Oil Inventories Plunge Much More Than Expected

India, May 20 -- The Energy Information Administration released a report on Wednesday showing crude oil inventories in the U.S. tumbled by much more than expected in the week ended May 15th.The report... Read More


Tamil gym owner warns 'you should not start a gym business in Chennai': '99% of it is fake'

India, May 20 -- Jayachandran Tamilarasan, a content creator, fitness coach, and founder of The Crew Fitness Chennai, sparked an online conversation after releasing a series of videos advising aspirin... Read More


प्रो त्रिविक्रम नारायण सिंह को दी गई विदायी

मुजफ्फरपुर, मई 20 -- मुजफ्फरपुर। बीआरएबीयू के पीजी हिन्दी विभाग में बुधवार को वरीय प्राध्यापक प्रो. त्रिविक्रम नारायण सिंह को विदाई दी गई। अध्यक्षता विभागाध्यक्ष प्रो. कुमारी आशा ने की। उन्होंने कहा क... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More